Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents

European Journal of Pharmacology

Volumn 737, Issue , 2014, Pages 97-105

  Wiley, Jenny L ^a,b   Walentiny, D Matthew ^b   Wright, M Jerry ^b   Beardsley, Patrick M ^b   Burston, James J ^b   Poklis, Justin L ^b   Lichtman, Aron H ^b   Vann, Robert E ^b  

^a RTI INTERNATIONAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

2 Arachidonoylglycerol; Anandamide; JZL184; PF3845; URB597

Indexed keywords

4 NITROPHENYL 4 [DIBENZO[D] 5 YL(HYDROXY)METHYL]PIPERADINE 1 CARBOXYLATE; ACYLGLYCEROL LIPASE; ANANDAMIDE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; N 3 PYRIDINYL 4 [[3 [[5 (TRIFLUOROMETHYL)2 PYRIDINYL]OXY]PHENYL]METHYL] 1 PIPERIDINECARBOXAMIDE; UNCLASSIFIED DRUG; 2-ARACHIDONYLGLYCEROL; ACYLGLYCEROL; AMIDASE; AMIDE; ARACHIDONIC ACID DERIVATIVE; CANNABINOID 1 RECEPTOR; ENZYME INHIBITOR; FATTY-ACID AMIDE HYDROLASE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CEREBELLUM; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; ENZYME INHIBITION; ENZYME METABOLISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DRUG EFFECTS; METABOLISM; PERCEPTIVE DISCRIMINATION; RAT;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; BRAIN; DISCRIMINATION (PSYCHOLOGY); DRONABINOL; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; MALE; MICE; MONOACYLGLYCEROL LIPASES; POLYUNSATURATED ALKAMIDES; RATS; RECEPTOR, CANNABINOID, CB1;

EID: 84901868882     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.05.013     Document Type: Article

References (42)

1. K. Ahn, D.S. Johnson, M. Mileni, D. Beidler, J.Z. Long, M.K. McKinney, E. Weerapana, N. Sadagopan, M. Liimatta, S.E. Smith, S. Lazerwith, C. Stiff, S. Kamtekar, K. Bhattacharya, Y. Zhang, S. Swaney, K. Van Becelaere, R.C. Stevens, and B.F. Cravatt Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain Chem. Biol. 16 2009 411 420
2. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci. Biobehav. Rev. 16 1992 55 62
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
4. R.T. Burkey, and J.R. Nation (R)-methanandamide, but not anandamide, substitutes for delta-9-THC in a drug-discrimination procedure Exp. Clin. Psychopharmacol. 5 1997 195 202 (Pubitemid 27346444)
5. J.J. Burston, L.J. Sim-Selley, J.P. Harloe, A. Mahadevan, R.K. Razdan, D.E. Selley, and J.L. Wiley N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase J. Pharmacol. Exp. Ther. 327 2008 546 553
6. B.F. Cravatt, K. Demarest, M.P. Patricelli, M.H. Bracey, D.K. Giang, B.R. Martin, and A.H. Lichtman Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase Proc. Natl. Acad. Sci. USA 98 2001 9371 9376 (Pubitemid 32743923)
7. B.F. Cravatt, and A.H. Lichtman The enzymatic inactivation of the fatty acid amide class of signaling lipids Chem. Phys. Lipids 121 2002 135 148 (Pubitemid 36044548)
8. T.P. Dinh, D. Carpenter, F.M. Leslie, T.F. Freund, I. Katona, S.L. Sensi, S. Kathuria, and D. Piomelli Brain monoglyceride lipase participating in endocannabinoid inactivation Proc. Natl. Acad. Sci. USA 99 2002 10819 10824
9. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, P. Carayon, M. Boulaboula, D. Shire, G. Le Fur, and P. Casellas Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur. J. Biochem. 232 1995 54 61
10. Y. Gaoni, and R. Mechoulam Isolation, structure, and partial synthesis of an active constituent of hashish J. Amer. Chem. Soc. 86 1964 1646 1647
11. 9-THC and CP-55,940 in rats and rhesus monkeys J. Pharmacol. Exp. Ther. 262 1992 479 486
12. A.I. Gulyas, B.F. Cravatt, M.H. Bracey, T.P. Dinh, D. Piomelli, F. Boscia, and T.F. Freund Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala Eur. J. Neurosci. 20 2004 441 458 (Pubitemid 38969629)
13. S. Hardison, S.T. Weintraub, and A. Giuffrida Quantification of endocannabinoids in rat biological samples by GC/MS: technical and theoretical considerations Prostaglandins Other Lipid Mediat 81 2006 106 112 (Pubitemid 44666493)
14. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabionoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 1991 563 583
15. M.N. Hill, and B.S. McEwan Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 34 2010 791 797
16. B.M. Ignatowska-Jankowska, S. Ghosh, M.S. Crowe, S.G. Kinsey, M.J. Niphakis, R.A. Abdullah, Q. Tao, S.T. O'Neal, D.M. Walentiny, J.L. Wiley, B.F. Cravatt, and A.H. Lichtman in vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects Br. J. Pharmacol. 171 2014 1392 1407
17. T.U. Järbe, R.J. Lamb, S. Lin, and A. Makriyannis (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide Psychopharmacology (Berlin) 156 2001 369 380 (Pubitemid 32695845)
18. T.U. Järbe, Q. Liu, and A. Makriyannis Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats Psychopharmacology (Berlin) 184 2006 36 45 (Pubitemid 43005755)
19. T.U.C. Järbe, and D.E. McMillan Discriminative stimulus properties of tetrahydrocannabinols and related drugs in rats and pigeons Neuropharmacology 18 1979 1023 1024 (Pubitemid 10117395)
20. D. Leung, A. Saghatelian, G.M. Simon, and B.F. Cravatt Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids Biochem 45 2006 4720 4726
21. J.Z. Long, W. Li, L. Booker, J.J. Burston, S.G. Kinsey, J.E. Schlosburg, F.J. Pavon, A.M. Serrano, D.E. Selley, L.H. Parsons, A.H. Lichtman, and B.F. Cravatt Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nature Chem. Biol 5 2009 37 44
22. J.Z. Long, D.K. Nomura, and B.F. Cravatt Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism Chem. Biol. 16 2009 744 753
23. J.Z. Long, D.K. Nomura, R.E. Vann, D.M. Walentiny, L. Booker, X. Jin, J.J. Burston, L.J. Sim-Selley, A.H. Lichtman, J.L. Wiley, and B.F. Cravatt Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc. Natl. Acad. Sci. U.S.A 106 2009 20270 20275
24. W.R. Marrs, J.L. Blankman, E.A. Horne, A. Thomazeau, Y.H. Lin, J. Coy, A.L. Bodor, G.G. Muccioli, S.S. Hu, G. Woodruff, S. Fung, M. Lafourcade, J.P. Alexander, J.Z. Long, W. Li, C. Xu, T. Moller, K. Mackie, O.J. Manzoni, B.F. Cravatt, and N. Stella The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors Nat. Neurosci. 13 2010 951 957
25. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol. Biochem. Behav. 40 1991 471 478
26. N. Matuszak, G.G. Muccioli, G. Labar, and D.M. Lambert Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors J. Med. Chem. 52 2009 7410 7420
27. L.R. McMahon, B.C. Ginsburg, and R.J. Lamb Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice Psychopharmacology (Berlin) 198 2008 487 495 (Pubitemid 351754667)
28. National Research Council Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research 2003 National Academies Press Washington, DC
29. S.M. Saario, O.M. Salo, T. Nevalainen, A. Poso, J.T. Laitinen, T. Jarvinen, and R. Niemi Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes Chem. Biol. 12 2005 649 656 (Pubitemid 43142042)
30. J.E. Schlosburg, J.L. Blankman, J.Z. Long, D.K. Nomura, B. Pan, S.G. Kinsey, P.T. Nguyen, D. Ramesh, L. Booker, J.J. Burston, E.A. Thomas, D.E. Selley, L.J. Sim-Selley, Q.S. Liu, A.H. Lichtman, and B.F. Cravatt Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat. Neurosci. 13 2010 1113 1119
31. J.C. Sipe, K. Chiang, A.L. Gerber, E. Beutler, and B.F. Cravatt A missense mutation in human fatty acid amide hydrolase associated with problem drug use Proc. Natl. Acad. Sci. USA 99 2002 8394 8399 (Pubitemid 34651063)
32. M. Solinas, G. Tanda, Z. Justinova, C.E. Wertheim, S. Yasar, D. Piomelli, S.K. Vadivel, A. Makriyannis, and S.R. Goldberg The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport J. Pharmacol. Exp. Ther. 321 2007 370 380 (Pubitemid 46456957)
33. M.D. Van Sickle, M. Duncan, P.J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J.S. Davison, L.J. Marnett, V. Di Marzo, Q.J. Pittman, K.D. Patel, and K.A. Sharkey Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
34. R.E. Vann, D.M. Walentiny, J.J. Burston, K.M. Tobey, T.F. Gamage, and J.L. Wiley Enhancement of the behavioral effects of endogenous and exogenous cannabinoid agonists by phenylmethyl sulfonyl fluoride Neuropharmacology 62 2012 1019 1027
35. R.E. Vann, J.A. Warner, K. Bushell, J.W. Huffman, B.R. Martin, and J.L. Wiley Discriminative stimulus properties of Delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice Eur. J. Pharmacol. 615 2009 102 107
36. D.M. Walentiny, T.F. Gamage, J.A. Warner, T.K. Nguyen, D.B. Grainger, J.L. Wiley, and R.E. Vann The endogenous cannabinoid anandamide shares discriminative stimulus effects with (9)-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice Eur. J. Pharmacol. 656 2011 63 67
37. J. Wiley, W. Ryan, R. Razdan, and B. Martin Evaluation of cannabimimetic effects of structural analogs of anandamide in rats Eur. J. Pharmacol. 355 1998 113 118 (Pubitemid 28404692)
38. J.L. Wiley, R.L. Barrett, D.T. Britt, R.L. Balster, and B.R. Martin Discriminative stimulus effects of delta 9-tetrahydrocannabinol and delta 9-11-tetrahydrocannabinol in rats and rhesus monkeys Neuropharmacology 32 1993 359 365 (Pubitemid 23122636)
39. J.L. Wiley, K.L. LaVecchia, N.E. Karp, S. Kulasegram, A. Mahadevan, R.K. Razdan, and B.R. Martin A comparison of the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats Exp. Clin. Psychopharmacol. 12 2004 173 179 (Pubitemid 38988713)
40. J.L. Wiley, J.A. Lowe, R.L. Balster, and B.R. Martin Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys J. Pharmacol. Exp. Ther. 275 1995 1 6
41. J.L. Wiley, D. Matthew Walentiny, R.E. Vann, and C.Y. Baskfield Dissimilar cannabinoid substitution patterns in mice trained to discriminate Delta(9)-tetrahydrocannabinol or methanandamide from vehicle Behav. Pharmacol. 22 2011 480 488
42. Z.X. Xi, X.Q. Peng, X. Li, R. Song, H.Y. Zhang, Q.R. Liu, H.J. Yang, G.H. Bi, J. Li, and E.L. Gardner Brain cannabinoid CB2 receptors modulate cocaine's actions in mice Nat. Neurosci. 14 2011 1160 1166